Skip to main content
SpringerLink
Log in

The usefulness of left atrial volume index and left ventricular mass index in determining subclinical cardiac involvement in patients with early-stage sarcoidosis

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background and aim

Sarcoidosis is a multi-systemic granulomatous disease of unknown etiology. The present study has been designed to evaluate the importance of diastolic dysfunction with left atrial volume index (LAVi) and left ventricular mass index (LVMi) in determining subclinical cardiac involvement in subjects with stage I–II pulmonary sarcoidosis.

Methods

A total of 54 patients under follow-up for sarcoidosis without cardiac involvement and 56 healthy subjects were included in the study. The echocardiographic assessment of the patients revealed no significant difference between the two groups regarding left ventricular end-systolic and end-diastolic diameters, ejection fraction (LVEF) and annular velocity determined by tissue Doppler evaluation.

Results

The LVEF calculated was 61.8 ± 7.8 % in the sarcoidosis group versus 64.1 ± 2.7 % in the control group (p = 0.04). Left ventricular interventricular septum thickness, posterior wall thickness, and relative wall thickness were significantly higher in the sarcoidosis group compared to the control group (p < 0.001). The sarcoidosis group had higher LVM and LVMi values compared to the control group (145 ± 18.1 and 79 ± 14 g/m2, 135 ± 27.7 and 74 ± 14.2 g/m2; p = 0.020 and p = 0.021, respectively). Left atrial end-systolic volume and LAVi were higher in the sarcoidosis group (28.7 ± 18.5; 15.6 ± 10.2) compared to the control group (16.6 ± 10.9; 8.9 ± 5.5) with a statistically significant difference (p < 0.001).

Conclusion

The present study indicates diastolic dysfunction and increased LVMi despite normal systolic function in patients with early-stage sarcoidosis without cardiac involvement. Also, the diastolic parameters were normal without showing any significant difference compared to the control group while there was a statistically significant increase in LAVi. This finding suggests that LAVi may be the earliest marker of diastolic dysfunction in patients with early-stage sarcoidosis without cardiac involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173

    CAS  PubMed  Google Scholar 

  2. Musellim B, Kumbasar OO, Ongen G et al (2009) Epidemiological features of Turkish patients with sarcoidosis. Respir Med 103:907–912

    Article  CAS  PubMed  Google Scholar 

  3. Fahy GJ, Marwick T, McCreery CJ et al (1996) Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109:62–66

    Article  CAS  PubMed  Google Scholar 

  4. Habersberger J, Manins V, Taylor AJ (2008) Cardiac sarcoidosis. Intern Med J 38:270–277

    Article  CAS  PubMed  Google Scholar 

  5. Kim JS, Judson MA, Donnino R et al (2009) Cardiac sarcoidosis. Am Heart J 157:9–21

    Article  CAS  PubMed  Google Scholar 

  6. Pierre-Louis B, Prasad A, Frishman WH (2009) Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev 17:153–158

    Article  PubMed  Google Scholar 

  7. Soejima K, Yada H (2009) The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 20:578–583

    Article  PubMed  Google Scholar 

  8. Dubrey SW, Falk RH (2010) Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 52:336–346

    Article  PubMed  Google Scholar 

  9. Youssef G, Beanlands RS, Birnie DH et al (2011) Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart 97:2078–2087

    Article  PubMed  Google Scholar 

  10. Shammas RL, Movahed A (1993) Sarcoidosis of the heart. Clin Cardiol 16:462–472

    Article  CAS  PubMed  Google Scholar 

  11. Roberts WC, McAllister HA Jr, Ferrans VJ (1997) Sarcoidosis of the heart: a clinico pathologic study of 35 necropys patients (group 1) and review of 78 previously described necropsy patients (group II). Am J Med 63:86–108

    Article  Google Scholar 

  12. Kahan T (1998) The importance of left ventricular hypertrophy in human hypertension. J Hypertens Suppl 16:23–29

    Article  Google Scholar 

  13. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) Recommendations regarding quantations in M-mode echocardiography: results of a survey and echocardiographic measurements. Circulation 58:1072–1078

    Article  CAS  PubMed  Google Scholar 

  14. Folland ED, Parisi AF, Moynihan PF et al (1979) Assessment of left ventricular ejection fraction and volumes by real-time, two dimensional echocardiography: a comparison of cineangiographic and radionuclide techniques. Circulation 60:760–766

    Article  CAS  PubMed  Google Scholar 

  15. Teichholz LE, Kreulen T, Herman MV et al (1976) Problems in echocardiographic volume determinations: echocardiographic-angiographic correlation in the presence or absence of asnergy. Am J Cardiol 37:7–12

    Article  CAS  PubMed  Google Scholar 

  16. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation 55:613–617

    Article  CAS  PubMed  Google Scholar 

  17. Johnson RA, Palacios I (1982) Dilated cardiomyopathies of the adult (second of two parts). N Eng J Med 30:1119

    Article  Google Scholar 

  18. Cepin D, McDonough M, James F (1983) Cardiac sarcoidosis—a case with unusual manifestations. Arch Intern Med 143:142–148

    Article  CAS  PubMed  Google Scholar 

  19. Lewin RF et al (1985) Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 110:166

    Article  Google Scholar 

  20. Sipahi S, İlerigelen B, Bilir M et al (1999) Sarkoidozda Sol ventrikül fonksiyonlarının ekokardiyografi Doppler yöntemiyle değerlendirilmesi. Turk Klin Cardiol 12:123–126

    Google Scholar 

  21. Focardi M, Picchi A, Nikiforakis N, Bargagli E, Fossi A, Maggiorelli C, Mondillo S, Rottoli P (2009) Assessment of cardiac involvement in sarcoidosis by echocardiography. Rheumatol Int 29:1051–1055

    Article  PubMed  Google Scholar 

  22. Fahy JG, Marwick T, McCreey J, Quigley PJ, Maurer JB et al (1996) Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109(l):62–66

    Article  CAS  PubMed  Google Scholar 

  23. Kaderli AA, Gullulu S, Coskun F, Yilmaz D, Uzaslan D (2010) Impaired left ventricular systolic and diastolic functions in patients with early grade pulmonary sarcoidosis. Eur J Echocardiogr 11:809–813. doi:10.1093/ejechocard/jeq070

    Article  Google Scholar 

  24. Seward JB, Casaclang-Verzosa G (2010) Infiltrative cardiovascular diseases. J Am Coll Cardiol 55(17):1769–1779. doi:10.1016/j.jacc.2009.12.040

    Article  PubMed  Google Scholar 

  25. Mayock RL, Bertrand P, Morrison CE (1963) Manifestations of sarcoidosis. Am J Med 35:67–89

    Article  CAS  PubMed  Google Scholar 

  26. Vignaux O, Dhote R, Duboc D et al (2002) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122:1895–1901

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Cardiology, Yıldırım Beyazıt University, Ankara, Turkey

    H. A. Kasapkara, H. Ayhan, T. Durmaz, T. Keleş & E. Bozkurt

  2. Department of Pulmonary Diseases, Ankara Ataturk Education and Research Hospital, Ankara, Turkey

    A. Şentürk

  3. Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent, 06800, Ankara, Turkey

    E. Bilen, B. Duran Karaduman, H. Ayhan & M. B. Özen

Authors
  1. H. A. Kasapkara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Şentürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Bilen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Duran Karaduman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Ayhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. B. Özen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Durmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Keleş
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E. Bozkurt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Ayhan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kasapkara, H.A., Şentürk, A., Bilen, E. et al. The usefulness of left atrial volume index and left ventricular mass index in determining subclinical cardiac involvement in patients with early-stage sarcoidosis. Ir J Med Sci 185, 617–621 (2016). https://doi.org/10.1007/s11845-015-1318-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-015-1318-1

Keywords

Search

Navigation